Lytix Biopharma: Invitation to Q2 2024 Results Presentation
Lytix Biopharma AS (Euronext Growth Oslo: LYTIX), a leading Norwegian immuno-oncology company, will release its second quarter 2024 financial results on Thursday, 29 August 2024. Date: Thursday, 29 August 2024Time: 10:00 AM CET Join us for a live webcast presentation featuring CEO Øystein Rekdal and CFO Gjest Breistein, where they will discuss the results and provide key insights. Q&A Session:We welcome your questions in advance. Please send them to post@lytixbiopharma.com, and they will be addressed during the Q&A session following the presentation. Webcast Details:The